Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02414672 · ClinicalTrials.gov registry record · NA

CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients

A NA study of Lung Cancer, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
317
Enrollment target
1
Study location

NCT02414672: Completed NA study of Lung Cancer, sponsored by Baylor College of Medicine.

NCT02414672 is a NA study of Lung Cancer that has completed, run by Baylor College of Medicine. The registered enrollment target is 317 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02414672, a NA study of Lung Cancer, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
317 participants
Enrollment target
1
Study location

Study Summary

The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the skills they need to provide care and meet the challenges of lung cancer, this intervention holds great promise for improving caregiver quality of life (QOL), patient QOL, and the quality of palliative and supportive care services offered to patients with advanced cancer and their families.

Primary Outcome

PROMIS Depression Short Form

Conditions Studied

Interventions

  • BEHAVIORAL CareSTEPS

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 317 participants
Start Date 2014-11
Est. Completion 2020-12
Phase NA
Baylor College of Medicine

616 total trials

What the finished NCT02414672 record still lists

NCT02414672 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which CareSTEPS is the first listed.

NCT02414672 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02414672 about?

NCT02414672 is a clinical study titled "CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients". The CareSTEPS intervention fills an important service gap by providing education, skills training, and support to the caregivers of advanced lung cancer patients on active treatment. The home-based delivery format will facilitate future dissemination and outreach. By empowering families with the ski...

What is the current status of trial NCT02414672?

This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2014-11. Estimated completion is 2020-12.

What conditions does trial NCT02414672 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT02414672?

The interventions under investigation include: CareSTEPS (BEHAVIORAL).

Who is sponsoring clinical trial NCT02414672?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02414672 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02414672's enrollment target sits among peer trials

317 97th of 409 higher than 313 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04594642 · 317 participants · Phase 1

    A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

  • NCT04977453 · 317 participants · Phase 1

    GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

  • NCT05137054 · 317 participants · Phase 1

    A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

  • NCT05382754 · 317 participants · NA

    Home Apnea Testing in CHildren Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02414672, the US trial registry maintained by the National Library of Medicine. NCT02414672 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.